Firivumab

Tax included
Firivumab (CT-P22; CT120) is a human IgG1 monoclonal influenza A virus hemagglutinin (Anti-IAV HA) antibody. Firivumab is capable of neutralizing H1N1, H5N1, H6N1, H6N2, H8N4, H8N8, H9N2 and H12N7. Firivumab shows protection against H1N1 virus in mice.
MedChemExpress 
HY-P99620

Data sheet

Size
Multiple sizes
Reactivity
Influenza Virus
Application
COVID-19-anti-virus
CAS
1443004-15-6